J 2019

Parallel in vitro and in silico investigations into anti-inflammatory effects of non-prenylated stilbenoids

LELÁKOVÁ, Veronika; Karel ŠMEJKAL; K. JAKUBCZYK; O. VESELY; P. LANDA et al.

Základní údaje

Originální název

Parallel in vitro and in silico investigations into anti-inflammatory effects of non-prenylated stilbenoids

Autoři

LELÁKOVÁ, Veronika ORCID; Karel ŠMEJKAL; K. JAKUBCZYK; O. VESELY; P. LANDA; Jiří VÁCLAVÍK; Pavel BOBÁĽ; Hana PÍŽOVÁ; V. TEMML; T. STEINACHER; D. SCHUSTER; S. GRANICA; Z. HANAKOVA a J. HOSEK

Vydání

Food Chemistry, Oxford, UK, Elsevier Science, 2019, 0308-8146

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 6.306

Označené pro přenos do RIV

Ne

Organizační jednotka

Farmaceutická fakulta

EID Scopus

Klíčová slova anglicky

Anti-inflammatory; Cyclooxygenase; Molecular docking simulations; Lipoxygenase; Macrophages; NF-kappa B; Stilbenes

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 17. 2. 2021 14:02, PharmDr. Jitka Michlíčková

Anotace

V originále

Stilbenoids represent a large group of bioactive compounds, which occur in food and medicinal plants. Twenty-five stilbenoids were screened in vitro for their ability to inhibit COX-1, COX-2 and 5-LOX. Piceatannol and pinostilbene showed activity comparable to the zileuton and ibuprofen, respectively. The anti-inflammatory potential of stilbenoids was further evaluated using THP-1 human monocytic leukemia cell line. Tests of the cytotoxicity on the THP-1 and HCT116 cell lines showed very low toxic effects. The tested stilbenoids were evaluated for their ability to attenuate the LPS-stimulated activation of NF-kappa B/AP-1. Most of the tested substances reduced the activity of NF-kappa B/AP-1 and later attenuated the expression of TNF-alpha. The effects of selected stilbenoids were further investigated on inflammatory signaling pathways. Non-prenylated stilbenoids regulated attenuation of NF-kappa B/AP-1 activity upstream by inhibiting the phosphorylation of MAPKs. A docking study used to in silico analyze the tested compounds confirmed their interaction with NF-kappa B, COX-2 and 5-LOX.